These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10822119)

  • 1. Adjusting survival analysis for the presence of unadjudicated study events.
    Cook TD
    Control Clin Trials; 2000 Jun; 21(3):208-22. PubMed ID: 10822119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A web-based endpoint adjudication system for interim analyses in clinical trials.
    Nolen TL; Dimmick BF; Ostrosky-Zeichner L; Kendrick AS; Sable C; Ngai A; Wallace D
    Clin Trials; 2009 Feb; 6(1):60-6. PubMed ID: 19254936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke.
    Levine SR; Brey RL; Tilley BC; Thompson JL; Sacco RL; Sciacca RR; Murphy A; Lu Y; Costigan TM; Rhine C; Levin B; Triplett DA; Mohr JP;
    JAMA; 2004 Feb; 291(5):576-84. PubMed ID: 14762036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular safety for once-weekly dulaglutide in type 2 diabetes: a pre-specified meta-analysis of prospectively adjudicated cardiovascular events.
    Ferdinand KC; Botros FT; Atisso CM; Sager PT
    Cardiovasc Diabetol; 2016 Feb; 15():38. PubMed ID: 26912057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher rates of coronary angiography and revascularization following myocardial infarction may be associated with greater survival in the United States than in Canada. The CARS Investigators (Coumadin/Aspirin Reinfarction Study).
    Langer A; Fisher M; Califf RM; Goodman S; O'Connor CM; Harrington RA; Fuster V
    Can J Cardiol; 1999 Oct; 15(10):1095-102. PubMed ID: 10523476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the benefit of event adjudication of cardiovascular outcomes in large simple RCTs.
    Pogue J; Walter SD; Yusuf S
    Clin Trials; 2009 Jun; 6(3):239-51. PubMed ID: 19528133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of independent data adjudication on hospital-specific estimates of risk-adjusted mortality following percutaneous coronary interventions in massachusetts.
    Barringhaus KG; Zelevinsky K; Lovett A; Normand SL; Ho KK
    Circ Cardiovasc Qual Outcomes; 2011 Jan; 4(1):92-8. PubMed ID: 21156880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of cardiovascular clinical events and impact of event adjudication on the treatment effect of darapladib versus placebo in patients with stable coronary heart disease: Insights from the STABILITY trial.
    Held C; White HD; Stewart RAH; Davies R; Sampson S; Chiswell K; Silverstein A; Lopes RD; Heldestad U; Budaj A; Mahaffey KW; Wallentin L;
    Am Heart J; 2019 Feb; 208():65-73. PubMed ID: 30572273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale, design, and protocol of a randomized controlled trial of the safety and efficacy of dabigatran etexilate versus dose-adjusted warfarin in patients with cerebral venous thrombosis.
    Ferro JM; Dentali F; Coutinho JM; Kobayashi A; Caria J; Desch M; Fraessdorf M; Huisman H; Diener HC
    Int J Stroke; 2018 Oct; 13(7):766-770. PubMed ID: 29775170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation.
    Assiri A; Al-Majzoub O; Kanaan AO; Donovan JL; Silva M
    Clin Ther; 2013 Jul; 35(7):967-984.e2. PubMed ID: 23870607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary stroke prevention with ximelagatran versus warfarin in patients with atrial fibrillation: pooled analysis of SPORTIF III and V clinical trials.
    Akins PT; Feldman HA; Zoble RG; Newman D; Spitzer SG; Diener HC; Albers GW
    Stroke; 2007 Mar; 38(3):874-80. PubMed ID: 17255547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction. Coumadin Aspirin Reinfarction Study (CARS) Investigators.
    Lancet; 1997 Aug; 350(9075):389-96. PubMed ID: 9259652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Efficacy and Safety of 3 Types of Interventions for Stroke Prevention in Patients With Cardiovascular and Cerebrovascular Diseases: A Network Meta-analysis.
    Sun Q; Chang S; Lu S; Zhang Y; Chang Y
    Clin Ther; 2017 Jul; 39(7):1291-1312.e8. PubMed ID: 28606562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS).
    O'Connor CM; Gattis WA; Hellkamp AS; Langer A; Larsen RL; Harrington RA; Berkowitz SD; O'Gara PT; Kopecky SL; Gheorghiade M; Daly R; Califf RM; Fuster V
    Am J Cardiol; 2001 Sep; 88(5):541-6. PubMed ID: 11524065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-stage adaptive design for clinical trials with survival data.
    Li G; Shih WJ; Wang Y
    J Biopharm Stat; 2005; 15(4):707-18. PubMed ID: 16022174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the Data and Safety Monitoring Committee (DSMC).
    Wilhelmsen L
    Stat Med; 2002 Oct; 21(19):2823-9. PubMed ID: 12325098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical endpoint adjudication in a contemporary all-comers coronary stent investigation: methodology and external validation.
    Vranckx P; McFadden E; Cutlip DE; Mehran R; Swart M; Kint PP; Zijlstra F; Silber S; Windecker S; Serruys PW
    Contemp Clin Trials; 2013 Jan; 34(1):53-9. PubMed ID: 22975439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
    Arjomand H; Cohen M; Ezekowitz MD
    J Invasive Cardiol; 2004 May; 16(5):271-8. PubMed ID: 15152137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Warfarin-Aspirin Recurrent Stroke Study (WARSS) trial: is warfarin really a reasonable therapeutic alternative to aspirin for preventing recurrent noncardioembolic ischemic stroke?
    Hankey GJ
    Stroke; 2002 Jun; 33(6):1723-6. PubMed ID: 12053018
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of weighted composite compared to traditional composite endpoints for the design of randomized controlled trials.
    Bakal JA; Westerhout CM; Armstrong PW
    Stat Methods Med Res; 2015 Dec; 24(6):980-8. PubMed ID: 22275378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.